[go: up one dir, main page]

FI93214B - Menetelmä ja välituote lääkeaineina käyttökelpoisten 0-(3-amino-2-hydroksipropyyli)-hydroksi-imiinihappohalidien valmistamiseksi - Google Patents

Menetelmä ja välituote lääkeaineina käyttökelpoisten 0-(3-amino-2-hydroksipropyyli)-hydroksi-imiinihappohalidien valmistamiseksi

Info

Publication number
FI93214B
FI93214B FI903075A FI903075A FI93214B FI 93214 B FI93214 B FI 93214B FI 903075 A FI903075 A FI 903075A FI 903075 A FI903075 A FI 903075A FI 93214 B FI93214 B FI 93214B
Authority
FI
Finland
Prior art keywords
hydroxyiminic
hydroxypropyl
drug
amino
preparation
Prior art date
Application number
FI903075A
Other languages
English (en)
Swedish (sv)
Other versions
FI903075A0 (fi
FI93214C (fi
Inventor
Nagy Peter Literati
Bela Balazs
Maria Boross
Jenoe Szilbereky
Gizella Zsila
Lajos Abraham
Gyoergy Blasko
Bela Gachalyi
Attila Almasi
Gabor Nemeth
Original Assignee
Biorex Kutato Fejlesztoe Kft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biorex Kutato Fejlesztoe Kft filed Critical Biorex Kutato Fejlesztoe Kft
Publication of FI903075A0 publication Critical patent/FI903075A0/fi
Publication of FI93214B publication Critical patent/FI93214B/fi
Application granted granted Critical
Publication of FI93214C publication Critical patent/FI93214C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
    • C07C259/04—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
    • C07C259/08—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
FI903075A 1988-10-20 1990-06-19 Menetelmä ja välituote lääkeaineina käyttökelpoisten 0-(3-amino-2-hydroksipropyyli)-hydroksi-imiinihappohalidien valmistamiseksi FI93214C (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
HU885405A HU207988B (en) 1988-10-20 1988-10-20 Process for producing halogenides of o-/3-amino-2-hydroxy-propyl/hydroximic acid and pharmaceutical compositions containing them as active components
HU540588 1988-10-20
HU8900048 1989-10-19
PCT/HU1989/000048 WO1990004584A1 (en) 1988-10-20 1989-10-19 Novel o-(3-amino-2-hydroxypropyl)-hydroximic acid halides and process for preparing the same

Publications (3)

Publication Number Publication Date
FI903075A0 FI903075A0 (fi) 1990-06-19
FI93214B true FI93214B (fi) 1994-11-30
FI93214C FI93214C (fi) 1995-03-10

Family

ID=10970243

Family Applications (1)

Application Number Title Priority Date Filing Date
FI903075A FI93214C (fi) 1988-10-20 1990-06-19 Menetelmä ja välituote lääkeaineina käyttökelpoisten 0-(3-amino-2-hydroksipropyyli)-hydroksi-imiinihappohalidien valmistamiseksi

Country Status (20)

Country Link
US (3) US5147879A (fi)
EP (1) EP0417210B1 (fi)
JP (1) JPH0819078B2 (fi)
KR (1) KR0154117B1 (fi)
AU (1) AU620460B2 (fi)
CA (1) CA2000830C (fi)
DE (1) DE68913737T2 (fi)
DK (1) DK175584B1 (fi)
ES (1) ES2020030A6 (fi)
FI (1) FI93214C (fi)
GR (1) GR1002253B (fi)
HU (1) HU207988B (fi)
IE (1) IE65113B1 (fi)
IL (1) IL92000A (fi)
NO (1) NO178148C (fi)
PL (1) PL164547B1 (fi)
PT (1) PT92041B (fi)
RU (1) RU2093508C1 (fi)
UA (1) UA34412C2 (fi)
WO (1) WO1990004584A1 (fi)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ285151A (en) * 1994-05-06 1998-09-24 Biorex Kutato Fejlesztoe Kft Hydroximic acid derivatives
US5665756A (en) * 1994-08-03 1997-09-09 Hoechst Marion Roussel, Inc. Aminoalkyloximes useful in the treatment of depression and obsessive compulsive disorders
HU9502843D0 (en) * 1995-09-29 1995-11-28 Livigene Ltd Pharmaceutical composition
HU222994B1 (hu) * 1995-11-02 2004-01-28 BIOREX Kutató és Fejlesztő Rt. Hidroxilaminszármazékok és azok alkalmazása sejtek molekuláris chaperon-termelésének fokozására alkalmas gyógyszerkészítmények előállítására
AU745987B2 (en) * 1995-12-22 2002-04-11 N-Gene Research Laboratories Inc. A cosmetic composition and a method for reducing the ageing processes of skin
US6884424B2 (en) 1995-12-22 2005-04-26 N-Gene Research Laboratories Inc. Method for treating the pathological lesions of the skin that develop by ultraviolet radiation of the sunlight
HUT78139A (hu) * 1995-12-22 2000-11-28 BIOREX Kutató és Fejlesztő Rt. Készítmény, különösen a bőr öregedési folyamatainak mérséklésére
US6458371B1 (en) 1995-12-22 2002-10-01 Medgene, Limited Cosmetic composition and a method for the prevention and/or reduction of the photoaging processes of the skin
HUT78138A (hu) 1995-12-22 2000-09-28 BIOREX Kutató és Fejlesztő Rt Hidroximsavszármazékot tartalmazó készítmény a növénytermesztés elősegítésére és alkalmazása
DE19607960A1 (de) * 1996-03-01 1997-09-04 Hoechst Schering Agrevo Gmbh Verfahren zur Herstellung von Ketonoximether durch Boronsäurekupplung
GB9613339D0 (en) * 1996-06-26 1996-08-28 Kritzinger Ann C Limp bookbinding assembly technique for two books in one pass
UA64716C2 (en) * 1996-08-09 2004-03-15 Pharmaceuticals for therapy or prevention of illnesses connected with dysfunction of vascular endothelial cells
HU220971B1 (hu) * 1997-04-03 2002-07-29 BIOREX Kutató és Fejlesztő Rt. Eljárás 0-(3-amino-2-hidroxi-propil)-hidroximsav-halogenidek előállítására
HU9701081D0 (en) 1997-06-23 1997-08-28 Gene Research Lab Inc N Pharmaceutical composition of antitumoral activity
WO2000007580A2 (en) * 1998-08-03 2000-02-17 N-Gene Kutató Kft. Pharmaceutical compositions against autoimmune diseases
HUP9900475D0 (en) * 1999-02-26 1999-04-28 Biorex Kutato Fejlesztoe Kft O-(3-piperidino-2-hydroxy-1-propyl)-hiyroximic acid-halogenid derivative, it's use for treating insulin resistance, and pharmaceutical compositions containing them as active component
US6933104B1 (en) 1999-04-23 2005-08-23 Shiva Biomedical, Llc Diagnosis and treatment of human kidney diseases
HUP0001583A2 (hu) * 2000-04-18 2002-11-28 BIOREX Kutató és Fejlesztő Rt. Egy piridin-1-oxid-származék és eljárás annak átalakítására gyógyászati hatású vegyületekké
PT1408966E (pt) * 2001-07-17 2008-05-02 N Gene Res Lab Inc Combinações farmacêuticas sinergísticas para a prevenção ou tratamento da diabetes
HUP0105205A2 (hu) * 2001-11-29 2003-08-28 BIOREX Kutató és Fejlesztő Rt. Metformint és egy hidroxilaminszármazékot tartalmazó, gyógyászati készítmény
DE60224841T2 (de) * 2001-12-21 2009-01-22 Rhodia Inc. Kombinierte stabile kationische und anionische tensidzusammensetzungen
JP2005514418A (ja) * 2002-01-11 2005-05-19 ビオレックス クタトー エス フェイレストェー アールテー． カルボキサミジン誘導体及び血管疾患の治療におけるそれらの使用
HUP0303584A3 (en) 2003-10-30 2009-12-28 Cytrx Corp Use of a hydroximic acid halide derivative in the treatment of neurodegenerative diseases
DE10351448A1 (de) * 2003-11-04 2005-06-09 Bayer Healthcare Ag Geschmackstoffhaltige Arzneimittelformulierungen mit verbesserten pharmazeutischen Eigenschaften
WO2008039514A1 (en) * 2006-09-26 2008-04-03 Cytrx Corporation Pharmaceutical compositions and methods for treating diseases associated with neurodegeneration
US7763601B2 (en) * 2006-11-02 2010-07-27 N-Gene Research Laboratories, Inc. Prevention and treatment of obesity
WO2010058779A1 (ja) 2008-11-18 2010-05-27 参天製薬株式会社 ピリジン－３－カルバルデヒド ｏ－（ピペリジン－１－イル－プロピル）－オキシム誘導体を有効成分として含有する網脈絡膜変性疾患の治療剤
HUP1100535A2 (en) 2011-09-26 2013-04-29 Bracelia Invest Ltd Pharmaceutical composition for enhancement of stem cell treatment
HUP1100534A2 (en) 2011-09-26 2013-04-29 Balazs Dr Hazay Pharmaceutical composition for the treatment of muscle atrophy
US20210145815A1 (en) 2017-09-22 2021-05-20 The University Of Adelaide Methods and products for improving sperm quality
KR101995300B1 (ko) 2018-03-30 2019-10-17 주식회사 아세아텍 다목적 관리기용 작업기 탈부착장치
HUP1800298A1 (hu) 2018-08-30 2020-05-28 N Gene Res Laboratories Inc Gyógyszerkombináció béta-receptor blokkolók hatásának módosítására és a mellékhatások csökkentésére
CN112174853B (zh) * 2020-11-03 2023-07-25 湖南经世新材料有限责任公司 一种氨解法制备（z）-n-羟基苯脒的方法
IL303026A (en) 2020-11-19 2023-07-01 Zevra Denmark As Processes for preparing arimoclomol citrate and intermediates thereof
US20240383853A1 (en) * 2021-09-28 2024-11-21 Zevra Denmark A/S Oximes and their use in treatment of gba-related diseases
AU2023454616A1 (en) 2023-07-10 2026-01-22 N-Gene Research Laboratories, Inc. Increasing telomere length and/or suppressing telomere shortening

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1670497C3 (de) * 1967-06-06 1973-12-20 Chinoin Gyogyszer- Es Vegyeszeti Termekek Gyara Rt, Budapest Isochinohnderivate und Verfahren zu deren Herstellung
HU177578B (en) * 1976-08-27 1981-11-28 Chinoin Gyogyszer Es Vegyeszet Process for preparing new 0-/3-amino-2-hydroxy-propyl/-amidoxime derivatives
US4187220A (en) * 1977-08-30 1980-02-05 Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara R.T. New O-(3-amino-2-hydroxy-propyl)-amidoxime derivatives, process for the preparation thereof and pharmaceutical compositions containing same
US4308399A (en) * 1977-08-30 1981-12-29 Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt. O-(3-Amino-2-hydroxy-propyl)-amidoxime derivatives, process for the preparation thereof and pharmaceutical compositions containing same
EP0369944A1 (de) * 1988-11-18 1990-05-23 Ciba-Geigy Ag Substituierte Oxadiaminobutane
FR2639942B1 (fr) * 1988-12-02 1991-03-29 Sanofi Sa Ethers oximes de propenone, procede pour leur preparation et compositions pharmaceutiques les contenant
HUT54347A (en) * 1989-01-10 1991-02-28 Chinoin Gyogyszer Es Vegyeszet Improved process for producing amidoximes

Also Published As

Publication number Publication date
PL164547B1 (pl) 1994-08-31
AU620460B2 (en) 1992-02-20
DK149790A (da) 1990-06-19
UA34412C2 (uk) 2001-03-15
JPH0819078B2 (ja) 1996-02-28
NO178148C (no) 1996-01-31
FI903075A0 (fi) 1990-06-19
DE68913737D1 (de) 1994-04-14
IL92000A0 (en) 1990-07-12
GR1002253B (en) 1996-04-23
EP0417210B1 (en) 1994-03-09
FI93214C (fi) 1995-03-10
CA2000830A1 (en) 1990-04-20
RU2093508C1 (ru) 1997-10-20
NO902703D0 (no) 1990-06-18
JPH03502931A (ja) 1991-07-04
PT92041B (pt) 1995-07-18
GR890100669A (el) 1990-11-29
HU207988B (en) 1993-07-28
KR900701741A (ko) 1990-12-04
DK175584B1 (da) 2004-12-13
WO1990004584A1 (en) 1990-05-03
CA2000830C (en) 1997-09-16
US5147879A (en) 1992-09-15
DE68913737T2 (de) 1994-07-28
KR0154117B1 (ko) 1998-12-01
HUT54110A (en) 1991-01-28
IE65113B1 (en) 1995-10-04
DK149790D0 (da) 1990-06-19
ES2020030A6 (es) 1991-07-16
NO178148B (no) 1995-10-23
US5296606A (en) 1994-03-22
NO902703L (no) 1990-06-18
US5328906A (en) 1994-07-12
PT92041A (pt) 1990-04-30
AU4418689A (en) 1990-05-14
IE893364L (en) 1990-04-20
IL92000A (en) 1994-06-24
EP0417210A1 (en) 1991-03-20

Similar Documents

Publication Publication Date Title
FI93214B (fi) Menetelmä ja välituote lääkeaineina käyttökelpoisten 0-(3-amino-2-hydroksipropyyli)-hydroksi-imiinihappohalidien valmistamiseksi
FI98196B (fi) Menetelmä mikroemulsion käsittävän farmaseuttisen formulaation valmistamiseksi
FI881978A0 (fi) Menetelmä eperisonia sisältävän farmaseuttisen koostumuksen valmistamiseksi
FI98046B (fi) Menetelmä syklosporiinia sisältävän farmaseuttisen koostumuksen valmistamiseksi
FI102182B1 (fi) Menetelmä ihmisen insuliinianalogien valmistamiseksi
FI871492A0 (fi) Menetelmä lääkeaineina käyttökelpoisten 2-tiometyyli-substituoitujen 1,4-dihydropyridiinien valmistamiseksi
FI901787A0 (fi) Menetelmä lääkkeenvälityskoostumuksen valmistamiseksi
FI900604A0 (fi) Menetelmä syklosporiinia sisältävän farmaseuttisen koostumuksen valmistamiseksi
NO863670D0 (no) Fremgangsmaate for fremstilling av et farmasoeytisk preparat av et hydrofobt legemiddel.
NO861331L (no) Fremgangsmaate for fremstilling av et hyaluronsyresalt.
FI905326A0 (fi) Menetelmä lääkeaineina käyttökelpoisten imidatso/4,5-b/kinolinyylioksialkaanihappoamidien valmistamiseksi
NO177038C (no) Fremgangsmåte for fremstilling av et farmasöytisk doseringssystem
NO166111C (no) Fremgangsmaate for fremstilling av et konfekt- eller farmasiprodukt.
PT90120A (pt) Processo para a preparacao de uma composicao farmaceutica contendo deprenil para administracao sistemica transdermica
FI880928A0 (fi) Menetelmä farmaseuttisen tabletin ja farmaseuttisen granulaatin valmistamiseksi
FI893520A0 (fi) Menetelmä intravenoosisen farmaseuttisen koostumuksen valmistamiseksi
NO175286C (no) Fremgangsmåte for fremstilling av et farmasöytisk preparat som omfatter dobbeltveggede mikrokapsler
FI891021A0 (fi) Menetelmä lääkeaineina käyttökelpoisten 1,2,4-triatsolijohdannaisten valmistamiseksi
FI893297A0 (fi) Menetelmä lääkeaineina käyttökelpoisten (atsa)naftaleenisultaamijohdannaisten valmistamiseksi
FI860101A0 (fi) Analogiamenetelmä uuden lääkkeen valmistamiseksi
NO883500L (no) Fremgangsmaate for fremstilling av et farmasoeytisk aktivt nitrometan.
FR2638640B1 (fr) Solution pharmaceutique
FI93107B (fi) Menetelmä lääkeaineina käyttökelpoisten 2-imino-6-polyfluorialkoksibentsotiatsolijohdannaisten valmistamiseksi
DK521487A (da) Farmaceutisk praeparat indeholdende et resorptionsforbedrende middel
NO179396C (no) Fremgangsmåte ved fremstilling av en medikamentell administreringsform for drövtyggere

Legal Events

Date Code Title Description
BB Publication of examined application
TC Name/ company changed in patent

Owner name: BIOREX KUTATO ES FEJLESZT! RT.

FG Patent granted

Owner name: BIOREX KUTATO ÉS FEJLESZTOE RT.

PC Transfer of assignment of patent

Owner name: CYTRX CORPORATION

Free format text: CYTRX CORPORATION